Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

PhRMA Representative Questions Follow-on Biologics Paper

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- In a letter to the editor published in this week's edition of The New England Journal of Medicine, Dr. David Wheadon, Senior Vice President of the Pharmaceutical Research and Manufacturers of America (PhRMA) Scientific & Regulatory Affairs team, attempts to set the record straight regarding a follow-on biologics (FOB) paper published in that medical journal last fall. The focus of Dr. Wheadon's criticism is a NEJM paper written by a New York patent attorney (Alfred Engelberg) and two Harvard professors (Dr. Aaron Kesselheim and Dr. Jerry Avorn), in which the three authors contend that the FOB...

Full post as published by Patent Docs on February 19, 2010 (boomark / email).